Regentis Biomaterials Ltd. (AMEX: RGNT) last traded at $1.60, down 5.88% on the session. The quote above updates while this page is open; the figures below are drawn from Regentis Biomaterials Ltd.’s own filings and are restated only when a new one is published.
Regentis Biomaterials Ltd. trades on AMEX under the ticker RGNT. Its market capitalisation is $8.29 million.
Valuation measures for Regentis Biomaterials Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $8.29M |
|---|---|
| Enterprise value | $3.78M |
| Price / book | 1.75 |
| Beta | 8.43 |
Trailing-twelve-month figures tagged in Regentis Biomaterials Ltd.'s XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$13.65M |
| Return on equity | -287.69% |
|---|
| Cash | $7.38M |
|---|
Range and volume for RGNT over the past 52 weeks.
| 52-week high | $15.50 |
|---|---|
| 52-week low | $1.23 |
| Volume | 22.2K |
| Average volume | 75.9K |
| Previous close | $1.70 |
Invest a chosen dollar amount in Regentis Biomaterials Ltd. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RGNT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.